Gene · 54888
Papers1,406
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,406
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CASC19 stabilization by ALYREF via m5C modification and its impact on SCD in colorectal cancer cell aggressiveness and stemness. | Cell Biosci | 2026 | 41794748 | PubTator, text mining | PubMed |
| Emerging roles of RNA N5-methylcytosine modification in reproductive physiology and gynecological diseases. | Epigenetics | 2026 | 41778387 | PubTator, text mining | PubMed |
| RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets. | MedComm (2020) | 2026 | 41756253 | PubTator, text mining | PubMed |
| m5C: Novel Diagnostic and Drug Repurposing Targets for Nonalcoholic Steatohepatitis. | Int J Genomics | 2026 | 41755884 | PubTator, text mining | PubMed |
| Research Progress on the Biological Function, Disease-Driving Mechanism and Clinical Targeting Strategies of G3BP2. | Molecules | 2026 | 41752399 | PubTator, text mining | PubMed |
| Short-Term Exposure to a 50 Hz Extremely Low-Frequency Electromagnetic Field (ELF-EMF) Leads to ROS-Mediated DNA Damage in Gynecological and Urological Cancer Cells In Vitro. | Int J Mol Sci | 2026 | 41751769 | PubTator, text mining | PubMed |
| Lactate metabolism and protein lactylation in cancer. | Mol Biomed | 2026 | 41746580 | PubTator, text mining | PubMed |
| Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer. | J Natl Cancer Cent | 2026 | 41738031 | PubTator, text mining | PubMed |
| Long non-coding RNAs in the exosomal network: dual roles and clinical implications in cancer. | Anim Cells Syst (Seoul) | 2026 | 41737608 | PubTator, text mining | PubMed |
| LncRNA SLC16A1-AS1 cooperates with NSUN2 to stabilize GRP78 mRNA via m5C modification in gastric cancer. | iScience | 2026 | 41727188 | PubTator, text mining | PubMed |
| DNMT2 inhibits anaplastic thyroid cancer progression by downregulating 5'tiRNAGly-GCC production. | Cell Death Dis | 2026 | 41723159 | PubTator, text mining | PubMed |
| Molecular mechanisms involved in Plasmodium gametocytogenesis. | Front Microbiol | 2026 | 41716278 | PubTator, text mining | PubMed |
| Lactylation in colorectal cancer: Unveiling novel mechanisms in metabolism, progression and therapeutic targeting. | Clin Transl Med | 2026 | 41711048 | PubTator, text mining | PubMed |
| Electroacupuncture and Moxibustion Regulate Aerobic Glycolysis and Alleviate Tumor Progression in Mice with Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2026 | 41710699 | PubTator, text mining | PubMed |
| Glycolysis enzymes and cellular lactylation in tumour. | Clin Transl Med | 2026 | 41705280 | PubTator, text mining | PubMed |
| GlycoRNAs: Biological functions and novel antiviral targets. | Virol Sin | 2026 | 41698513 | PubTator, text mining | PubMed |
| m5c-modified LINC01094 participates in epithelial-mesenchymal transition and metastasis of cervical cancer cells via the ZNF582-SIRT1/p53 axis. | Mamm Genome | 2026 | 41632300 | PubTator, text mining | PubMed |
| AI-driven virtual screening platform identifies novel NSUN2 inhibitor candidates for targeted cancer therapy: a computational drug discovery approach. | NPJ Precis Oncol | 2026 | 41617787 | PubTator, text mining | PubMed |
| Transcriptomic integration nominates FOXN2 as a candidate schizophrenia risk gene. | Behav Brain Res | 2026 | 41616909 | PubTator, text mining | PubMed |
| Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications. | Biomark Res | 2026 | 41593811 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54888/papers?page=4